Home - Products - Angiogenesis - PDE - Triflusal

Triflusal

CAS No. 322-79-2

Triflusal( Triflusal, Disgren, Grendis, Aflen, Triflux )

Catalog No. M14050 CAS No. 322-79-2

Triflusal is a platelet aggregation inhibitor that was discovered and developed in the Uriach Laboratories, and commercialised in Spain since 1981.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
1 mL x 10 mM in DMSO	41	In Stock
5MG	37	In Stock
10MG	49	In Stock
25MG	73	In Stock
50MG	91	In Stock
100MG	126	In Stock
200MG	Get Quote	In Stock
500MG	230	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Triflusal
Note

Research use only, not for human use.
Brief Description

Triflusal is a platelet aggregation inhibitor that was discovered and developed in the Uriach Laboratories, and commercialised in Spain since 1981.
Description

Triflusal is a platelet aggregation inhibitor that was discovered and developed in the Uriach Laboratories, and commercialised in Spain since 1981. Currently, it is available in 25 countries in Europe, Asia, Africa and America. It is a drug of the salicylate family but it is not a derivative of acetylsalicylic acid (ASA).
In Vitro

——
In Vivo

——
Synonyms

Triflusal, Disgren, Grendis, Aflen, Triflux
Pathway

Angiogenesis
Target

PDE
Recptor

PDE| TXA2R
Research Area

Inflammation/Immunology
Indication

——

Chemical Information

CAS Number

322-79-2
Formula Weight

248.16
Molecular Formula

C10H7F3O4
Purity

>98% (HPLC)
Solubility

Ethanol: 50 mg/mL (201.48 mM); DMSO: 50 mg/mL (201.48 mM)
SMILES

O=C(O)C1=CC=C(C(F)(F)F)C=C1OC(C)=O
Chemical Name

2-acetyloxy-4-(trifluoromethyl)benzoic acid

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1.Acta Crystallographica Section A, 49 ( Pt 1), 10-22 (1993)

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Udenafil

A potent and selective phosphodiesterase 5 (PDE5) inhibitor for treat erectile dysfunction.
Enoximone

Enoximone is a selective inhibitor of phosphodiesterase III (PDE3), with treatment of congestive heart failure.
Filaminast

Filaminast (WAY-PDA-641;PDA-641;WAY-123641) is a potent and selective PDE4 inhibitor with IC50 of 420 nM, displays 36-fold selectivity over PDE3.

Sign In Join Free